Kidney cancer drug shows promise against dangerous calcium imbalance caused by tumors
Elevated calcium levels in the blood—a complication of kidney cancers known as hypercalcemia—may be successfully treated with a class of medications called HIF-2α inhibitors developed by UT Southwestern Medical Center, ...
Oct 9, 2025
0
0


